"
Tarlatamab in Small-Cell Lung Cancer: Clinical Validation of DLL3 as a Therapeutic Target"
written by Gustavo Alberto Gutiérrez-Barros, María Victoria Morales-Morales, Carlos Andrés Morales Padilla, Sofía Margarita Marzan Reyes, Juan Felipe Díaz Pérez, Luis Enrique Velez Cantor, Karen Alejandra Montes Valencia, Edwin Javier Delgado Caliz, Sergio Andrés Vides Ricaurte, Isabella Pizarro Castillo,
published by
Journal of Biosciences and Medicines,
Vol.14 No.7, 2026
has been cited by the following article(s):